| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| stannsoporfin | heme oxygenase 1 | small molecule | Clinical trial target | TTD , drugbank , DGIDB | Liver diseases[MeSHID:D008107] Metabolic Diseases[MeSHID:D008659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hyperbilirubinemia Neonatal[MeSHID:D051556] |
55.69 | investigational,phase 2 | unknown |
| stannsoporfin | heme oxygenase 2 | small molecule | NA | drugbank , DGIDB | Liver diseases[MeSHID:D008107] Metabolic Diseases[MeSHID:D008659] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hyperbilirubinemia Neonatal[MeSHID:D051556] |
63.65 | investigational | unknown |
| click here to return to the previous page | ||||||||